Zhenzhen Li

发表

ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer

C. Xie, Zhihao Wang, Shaoxing Sun, 2015, Cancer biology & therapy.

SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.

Junhong Zhang, C. Xie, Shaoxing Sun, 2017, Oncology reports.

Whole-Exome Sequencing Uncovers Specific Genetic Variation Difference Based on Different Modes of Drug Resistance in Small Cell Lung Cancer

Xiao Han, Haiyong Wang, Zhenzhen Li, 2022, Frontiers in Oncology.

Immunophenotyping of pulmonary sarcomatoid carcinoma

Tao Jiang, Zhenzhen Li, Jianfei Zhu, 2022, Frontiers in Immunology.

Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies

Shuangxiu Wu, Zhenxiang Li, Chenyue Zhang, 2022, Cancer science.

Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma.

Xiaojuan Xiao, Jing Liu, Lei Hu, 2022, Cancer letters.

Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma

Xiaojuan Xiao, Zhenzhen Li, Haiqin Wang, 2023, Cancers.

Lycorine targets multiple myeloma stem cell‐like cells by inhibition of Wnt/β‐catenin pathway

Mao Ye, Wen Zhou, Jiliang Xia, 2020, British journal of haematology.

Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma.

Huiyang Zhou, Xiaojuan Xiao, Xifeng Liu, 2022, Cancer letters.

Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma.

Mao Ye, Xiaojuan Xiao, Jing Liu, 2021, Cancer letters.

Anti-BCMA surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.

Mao Ye, Xiaojuan Xiao, Xifeng Liu, 2023, Biomaterials.

Intratumor heterogeneity is associated with less CD8+ T cell infiltration and worse survival in patients with small cell lung cancer

Chenyue Zhang, Haiyong Wang, Zhenzhen Li, 2022, Clinical and Translational Oncology.